SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹13 Cr | ₹11 Cr | ₹8.14 Cr | ₹1.01 Cr | ₹9.37 Cr |
What is the latest Total Non-Current Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹8.14 Cr |
| Mar2022 | ₹1.01 Cr |
| Mar2021 | ₹9.37 Cr |
How is Total Non-Current Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹13 Cr | 20.42 | |
| Mar2024 | ₹11 Cr | 33.16 | |
| Mar2023 | ₹8.14 Cr | 709.34 | |
| Mar2022 | ₹1.01 Cr | -89.26 | |
| Mar2021 | ₹9.37 Cr | - | |
Compare Total Non-Current Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹100.0 Cr | -5.3% | -15.1% | -25.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -5.3% |
-15.1% |
-25.9% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses